OR-OPEN19-FOUNDATION
4.6.2019 12:02:07 CEST | Business Wire | Press release
The Open19 Foundation, an organization established to create a community for a new generation of open data centers and edge solutions, today announced its membership within the Kinetic Edge™ Alliance (KEA) as a technology partner. The future of computing is at the edge, and this partnership will accelerate deployment of Open19 infrastructure into edge locations.
“The Kinetic Edge Alliance is the de-facto alliance that is creating order and a blueprint to build the edge technology specifically for edge cloud applications,” said Yuval Bachar, Open19 Foundation President. “The Open19 Foundation will join the Kinetic Edge Alliance to add the hardware buildout building block to the alliance with the Open19 platform. The Open19 platform is designed for the edge and optimized for the solution as defined by the Kinetic Edge alliance. It will enable a standard but flexible solution for building the Edge platforms of the present and the future.”
Founded by Open19 Foundation member company Vapor IO , the Kinetic Edge Alliance is an industry working group dedicated to making edge computing easy and connecting stakeholders with end users and customers. Other members of the group include Packet, New Continuum Data Centers, and Seagate. Learn more about the Alliance here .
“The Open19 standard makes it fast and economical to deploy equipment in edge environments,” said Matt Trifiro, CMO of Vapor IO. “By offering a chassis design that slides in and out of a rack, installing or swapping out data center equipment becomes almost as easy as opening and closing a desk drawer. This makes it possible for technicians to deploy or repair edge equipment in minutes instead of hours or days.”
Twelve partner companies launched the Kinetic Edge Alliance in February 2019 for the purpose of driving broad adoption of compute, storage, access and interconnection at the edge of the cellular network, simplifying edge computing for the masses. The Alliance is actively rolling out equipment and services across the top 30 major metropolitan US markets, beginning with the first six markets in 2019. The Alliance seeks to deploy, in lockstep, all of the key hardware and software infrastructure components that will enable commercial-grade edge computing at scale. There are now nearly 40 partner companies in the Alliance.
About the Open19 Foundation
The Open19 Foundation was established in 2017 by founding members Flex, GE Digital, Hewlett Packard Enterprise, LinkedIn, Packet, and Vapor IO to create a community that will enable a common optimized data center and edge solutions. It has since grown to 26 members from all parts of the edge ecosystem – from component and system suppliers and integrators, to data center operators. For more information, visit the Foundation’s website at www.open19.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190604005313/en/
Contact:
Open19 Foundation Rachael Watson, PR manager rwatson@nereus-worldwide.com (971) 706-1312
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom